SG’s Mount Elizabeth Hospital bets on precision medicine to personalise care
It will apply precision medicine to neurology, amongst others.
Singapore’s Mount Elizabeth Hospital (MEH) has launched its Precision Medicine Hub, aiming to connect specialist expertise, diagnostics, infrastructure and clinical capabilities.
In a press release, the hospital said the hub will apply precision medicine to neurology, cancer care, paediatrics, cardiology, and reproductive and fertility-related care for women.
"If done well, this can lead to real personalised care paths, improving the healthspan of the patients, and create new opportunities for value-based care,” Yong Yih Ming, Chief Operating Officer, IHH Healthcare Singapore and CEO of MEH, said.
Moreover, genomics will be a starting point with insights that can inform preventive and curative care across specialities.
The report cited studies which noted that 3.4% of Asians carry a medically actionable genetic variant, whilst 99.7% carry at least one actionable pharmacogenomic variant that could influence how they respond to certain medications.
Notably, 26.8% of Asians carry a genetic variant associated with an increased risk of a life-threatening drug reaction.